Assuntos
Anestesia Geral/métodos , Anestesia Obstétrica/métodos , Raquianestesia/métodos , Procedimentos Cirúrgicos em Ginecologia/métodos , Anestesia Geral/mortalidade , Anestesia Obstétrica/mortalidade , Raquianestesia/mortalidade , Feminino , Procedimentos Cirúrgicos em Ginecologia/mortalidade , Humanos , Reprodutibilidade dos Testes , Resultado do TratamentoAssuntos
Humanos , Feminino , Procedimentos Cirúrgicos em Ginecologia/métodos , Anestesia Geral/métodos , Anestesia Obstétrica/métodos , Raquianestesia/métodos , Procedimentos Cirúrgicos em Ginecologia/mortalidade , Reprodutibilidade dos Testes , Resultado do Tratamento , Anestesia Geral/mortalidade , Anestesia Obstétrica/mortalidade , Raquianestesia/mortalidadeRESUMO
CONTEXT AND OBJECTIVE: Taking the outcome of mortality into consideration, there is controversy about the beneficial effects of neuraxial anesthesia for orthopedic surgery. The aim of this study was to compare the effectiveness and safety of neuraxial anesthesia versus general anesthesia for orthopedic surgery. DESIGN AND SETTING: Systematic review at Universidade Federal de Alagoas. METHODS: We searched the Cochrane Central Register of Controlled Trials (Issue 10, 2012), PubMed (1966 to November 2012), Lilacs (1982 to November 2012), SciELO, EMBASE (1974 to November 2012) and reference lists of the studies included. Only randomized controlled trials were included. RESULTS: Out of 5,032 titles and abstracts, 17 studies were included. There were no statistically significant differences in mortality (risk difference, RD: -0.01; 95% confidence interval, CI: -0.04 to 0.01; n = 1903), stroke (RD: 0.02; 95% CI: -0.04 to 0.08; n = 259), myocardial infarction (RD: -0.01; 95% CI: -0.04 to 0.02; n = 291), length of hospitalization (mean difference, -0.05; 95% CI: -0.69 to 0.58; n = 870), postoperative cognitive dysfunction (RD: 0.00; 95% CI: -0.04 to 0.05; n = 479) or pneumonia (odds ratio, 0.61; 95% CI: 0.25 to 1.49; n = 167). CONCLUSION: So far, the evidence available from the studies included is insufficient to prove that neuraxial anesthesia is more effective and safer than general anesthesia for orthopedic surgery. However, this systematic review does not rule out clinically important differences with regard to mortality, stroke, myocardial infarction, length of hospitalization, postoperative cognitive dysfunction or pneumonia.
Assuntos
Anestesia Epidural/mortalidade , Raquianestesia/mortalidade , Procedimentos Ortopédicos , Anestesia Epidural/normas , Anestesia Geral/mortalidade , Anestesia Geral/normas , Raquianestesia/normas , Transtornos Cognitivos/etiologia , Feminino , Humanos , Tempo de Internação , Masculino , Infarto do Miocárdio/etiologia , Pneumonia/etiologia , Ensaios Clínicos Controlados Aleatórios como Assunto , Medição de Risco , Acidente Vascular Cerebral/etiologiaRESUMO
BACKGROUND: Lower-limb revascularization is a surgical procedure that is performed to restore an adequate blood supply to the limbs. Lower-limb revascularization surgery is used to reduce pain and sometimes to improve lower-limb function. Neuraxial anaesthesia is an anaesthetic technique that uses local anaesthetics next to the spinal cord to block nerve function. Neuraxial anaesthesia may lead to improved survival. This systematic review was originally published in 2010 and was first updated in 2011 and again in 2013. OBJECTIVES: To determine the rates of death and major complications associated with spinal and epidural anaesthesia as compared with other types of anaesthesia for lower-limb revascularization in patients aged 18 years or older who are affected by obstruction of lower-limb vessels. SEARCH METHODS: The original review was published in 2010 and was based on a search until June 2008. In 2011 we reran the search until February 2011 and updated the review. For this second updated version of the review, we searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, LILACS, CINAHL and Web of Science from 2011 to April 2013. SELECTION CRITERIA: We included randomized controlled trials comparing neuraxial anaesthesia (spinal or epidural anaesthesia) versus other types of anaesthesia in adults (18 years or older) with arterial vascular obstruction undergoing lower-limb revascularization surgery. DATA COLLECTION AND ANALYSIS: Two review authors independently performed data extraction and assessed trial quality. We pooled the data on mortality, myocardial infarction, lower-limb amputation and pneumonia. We summarized dichotomous data as odds ratio (OR) with 95% confidence interval (CI) using a random-effects model. MAIN RESULTS: In this updated version of the review, we found no new studies that met our inclusion criteria. We included in this review four studies that compared neuraxial anaesthesia with general anaesthesia. The total number of participants was 696, of whom 417 were allocated to neuraxial anaesthesia and 279 to general anaesthesia. Participants allocated to neuraxial anaesthesia had a mean age of 67 years, and 59% were men. Participants allocated to general anaesthesia had a mean age of 67 years, and 66% were men. Four studies had an unclear risk of bias. No difference was observed between participants allocated to neuraxial or general anaesthesia in mortality rate (OR 0.89, 95% CI 0.38 to 2.07; 696 participants; four trials), myocardial infarction (OR 1.23, 95% CI 0.56 to 2.70; 696 participants; four trials), and lower-limb amputation (OR 0.84, 95% CI 0.38 to 1.84; 465 participants; three trials). Pneumonia was less common after neuraxial anaesthesia than after general anaesthesia (OR 0.37, 95% CI 0.15 to 0.89; 201 participants; two trials). Evidence was insufficient for cerebral stroke, duration of hospital stay, postoperative cognitive dysfunction, complications in the anaesthetic recovery room and transfusion requirements. No data described nerve dysfunction, postoperative wound infection, patient satisfaction, postoperative pain score, claudication distance and pain at rest. AUTHORS' CONCLUSIONS: Available evidence from included trials that compared neuraxial anaesthesia with general anaesthesia was insufficient to rule out clinically important differences for most clinical outcomes. Neuraxial anaesthesia may reduce pneumonia. No conclusions can be drawn with regard to mortality, myocardial infarction and rate of lower-limb amputation, or less common outcomes.
Assuntos
Anestesia Epidural/efeitos adversos , Anestesia Geral/efeitos adversos , Raquianestesia/efeitos adversos , Extremidade Inferior/irrigação sanguínea , Idoso , Amputação Cirúrgica/estatística & dados numéricos , Anestesia Epidural/mortalidade , Anestesia Geral/mortalidade , Raquianestesia/mortalidade , Feminino , Humanos , Extremidade Inferior/cirurgia , Masculino , Infarto do Miocárdio/epidemiologia , Pneumonia/epidemiologia , Ensaios Clínicos Controlados Aleatórios como Assunto , Procedimentos Cirúrgicos VascularesRESUMO
CONTEXT AND OBJECTIVE: Taking the outcome of mortality into consideration, there is controversy about the beneficial effects of neuraxial anesthesia for orthopedic surgery. The aim of this study was to compare the effectiveness and safety of neuraxial anesthesia versus general anesthesia for orthopedic surgery. DESIGN AND SETTING: Systematic review at Universidade Federal de Alagoas. METHODS: We searched the Cochrane Central Register of Controlled Trials (Issue 10, 2012), PubMed (1966 to November 2012), Lilacs (1982 to November 2012), SciELO, EMBASE (1974 to November 2012) and reference lists of the studies included. Only randomized controlled trials were included. RESULTS: Out of 5,032 titles and abstracts, 17 studies were included. There were no statistically significant differences in mortality (risk difference, RD: -0.01; 95% confidence interval, CI: -0.04 to 0.01; n = 1903), stroke (RD: 0.02; 95% CI: -0.04 to 0.08; n = 259), myocardial infarction (RD: -0.01; 95% CI: -0.04 to 0.02; n = 291), length of hospitalization (mean difference, -0.05; 95% CI: -0.69 to 0.58; n = 870), postoperative cognitive dysfunction (RD: 0.00; 95% CI: -0.04 to 0.05; n = 479) or pneumonia (odds ratio, 0.61; 95% CI: 0.25 to 1.49; n = 167). CONCLUSION: So far, the evidence available from the studies included is insufficient to prove that neuraxial anesthesia is more effective and safer than general anesthesia for orthopedic surgery. However, this systematic review does not rule out clinically important differences with regard to mortality, stroke, myocardial infarction, length of hospitalization, postoperative cognitive dysfunction or pneumonia. .
CONTEXTO E OBJETIVO: Considerando o desfecho de mortalidade, existe controvérsia acerca dos efeitos benéficos da anestesia neuroaxial (AN) para cirurgias ortopédicas. O objetivo do estudo foi comparar efetividade e segurança da AN versus anestesia geral (AG) para cirurgias ortopédicas. TIPO DE ESTUDO E LOCAL: Revisão sistemática na Universidade Federal de Alagoas. MÉTODOS: Buscamos em Cochrane Central Register of Controlled Trials (2012, volume 10), PubMed (1966 até novembro de 2012), Lilacs (1982 até novembro de 2012), SciELO, EMBASE (1974 até novembro de 2012) e listas de referências dos estudos incluídos. Apenas ensaios clínicos randomizados foram incluídos. RESULTADOS: Dentre 5.032 títulos e resumos, 17 estudos foram incluídos. Não houve diferença estatística em mortalidade (diferença de risco, DR: -0,01; intervalo de confiança de 95%, IC: -0,04 a 0.01; n = 1903), em acidente vascular encefálico (DR: 0,02; IC 95%: -0,04 a 0,08; n = 259, em infarto miocárdico (DR: -0.01; IC 95%: -0,04 a 0.02; n = 291), tempo de hospitalização (diferença média, -0,05; IC 95%: -0,69 a 0,58; n = 870), em disfunção cognitiva pós-operatória (DR: 0,00; IC 95%: -0,04 a 0,05; n = 479) e pneumonia (razão de chances, 0,61; IC 95%: 0,25 a 1,49; n = 167). CONCLUSÃO: Até o momento, as evidências são insuficientes nos estudos incluídos para provar que AN é mais efetiva e segura do que AG para cirurgias ortopédicas. Esta revisão sistemática não descartou diferenças clínicas importantes para mortalidade, acidente vascular encefálico, infarto miocárdico, tempo de internação, disfunção cognitiva pós-operatória e pneumonia. .